Why are potential dangerous phthalates allowed in medical devices, and who decides if their use is warranted?
GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
12th Meeting of the Working Group on Guidelines on benefit – risk assessment of Phthalates in Medical Devices
Hearing on the SCHEER preliminary Guidelines on the presence of Phthalates in certain medical devices (Brussels, 04 April 2019) – Summary records and presentations now available
PUBLIC CONSULTATION ON PHTHALATES IN MEDICAL DEVICES – Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices